MDR Charting, page-219

Thought I might defib the Charting thread.

We're half way through July and there's only been 5 days where there's been trades.

The volume has been tiny. Last Friday a total of $310.

The CEO bought $10k on market when we were at 3c in April 2016.
http://www.asx.com.au//asxpdf/20160408/pdf/436d9bp91c108v.pdf

He then bought $23k at 4.2c in October 2016.
http://www.asx.com.au//asxpdf/20161021/pdf/43c5gwtd70pcqx.pdf

It's usually around July where the announce either new or renewals of Patient Engagement Programs.

I sense Management might be sandbagging some news and there might be a flurry released around the quarterly (end of July / August).

The quarterly this time last year the share price was 4 cents+:
http://www.asx.com.au//asxpdf/20160729/pdf/438y7qr6qh9xnw.pdf

- 180,000 connected users in July 16.
I suspect 800,000 will be announced this quarter.

- 1600 pharmacies in July 16.
I suspect 2700 will be announced this quarter.

- 9 vendors engaged with PEP in July 16.
I suspect we'll see double digits announced this quarter.

- GP Link was still in beta in July 16.
I suspect 4500+ connected GPs will be announced this quarter.

The indicators which measure revenue are getting bigger. Management state they are fully funded until they reach cash flow neutral in 2018, not discounting other takeover opportunities. They continue to grow at an Executive level so obviously have a strategy that sees the platform reaching other revenue streams not yet announced.

With the last two months dropping in volume, the spring appears to be getting tighter. On screen there is very little to scoop up until 3.7c. I hope for a healthy rise when the quarterly is published.